Report: Developing Opportunities within 22nd Century Group,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
32
Report: Developing Opportunities within 22nd Century Group, Darling Ingredients, Silvercorp Metals, Trevena, Star Bulk Carriers, and AngioDynamics — Future Expectations, Projections Moving into 2019

NEW YORK, April 05, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of 22nd Century Group, Inc (NYSE: XXII ), Darling Ingredients Inc. (NYSE: DAR ), Silvercorp Metals Inc. (NYSE: SVM ), Trevena, Inc. (NASDAQ: TRVN ), Star Bulk Carriers Corp. (NASDAQ: SBLK ), and AngioDynamics, Inc. (NASDAQ: ANGO ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

XXII DOWNLOAD: http://Capital-Review.com/register/?so=XXII DAR DOWNLOAD: http://Capital-Review.com/register/?so=DAR SVM DOWNLOAD: http://Capital-Review.com/register/?so=SVM TRVN DOWNLOAD: http://Capital-Review.com/register/?so=TRVN SBLK DOWNLOAD: http://Capital-Review.com/register/?so=SBLK ANGO DOWNLOAD: http://Capital-Review.com/register/?so=ANGO

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Capital Review, available for free download at the links above, examine 22nd Century Group, Inc (NYSE: XXII ), Darling Ingredients Inc. (NYSE: DAR ), Silvercorp Metals Inc. (NYSE: SVM ), Trevena, Inc. (NASDAQ: TRVN ), Star Bulk Carriers Corp. (NASDAQ: SBLK ), and AngioDynamics, Inc. (NASDAQ: ANGO ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

22ND CENTURY GROUP, INC (XXII) REPORT OVERVIEW

22nd Century Group's Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, 22nd Century Group reported revenue of $7.14MM vs $5.94MM (up 20.11%) and analysts estimated basic earnings per share -$0.07 vs -$0.03. For the twelve months ended December 31st, 2018 vs December 31st, 2017, 22nd Century Group reported revenue of $26.43MM vs $16.60MM (up 59.19%) and analysts estimated basic earnings per share -$0.06 vs -$0.13. Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019.

To read the full 22nd Century Group, Inc (XXII) report, download it here: http://Capital-Review.com/register/?so=XXII

-----------------------------------------

DARLING INGREDIENTS INC. (DAR) REPORT OVERVIEW

Darling Ingredients' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Darling Ingredients reported revenue of $853.13MM vs $952.55MM (down 10.44%) and analysts estimated basic earnings per share $0.25 vs $0.63 (down 60.32%). For the twelve months ended December 31st, 2018 vs December 31st, 2017, Darling Ingredients reported revenue of $3,387.73MM vs $3,662.25MM (down 7.50%) and analysts estimated basic earnings per share $0.62 vs $0.78 (down 20.51%). Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.58. The estimated EPS forecast for the next fiscal year is $1.06 and is expected to report on February 26th, 2020.

To read the full Darling Ingredients Inc. (DAR) report, download it here: http://Capital-Review.com/register/?so=DAR

-----------------------------------------

SILVERCORP METALS INC. (SVM) REPORT OVERVIEW

Silvercorp Metals' Recent Financial Performance

For the three months ended December 31st, 2018 vs December 31st, 2017, Silvercorp Metals reported revenue of $42.35MM vs $44.35MM (down 4.51%) and analysts estimated basic earnings per share $0.05 vs $0.08 (down 37.50%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Silvercorp Metals reported revenue of $170.04MM vs $163.47MM (up 4.02%) and analysts estimated basic earnings per share $0.28 vs $0.26 (up 7.69%). Analysts expect earnings to be released on May 23rd, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.04. The estimated EPS forecast for the next fiscal year is $0.21 and is expected to report on May 23rd, 2019.

To read the full Silvercorp Metals Inc. (SVM) report, download it here: http://Capital-Review.com/register/?so=SVM

-----------------------------------------

TREVENA, INC. (TRVN) REPORT OVERVIEW

Trevena's Recent Financial Performance

Analysts expect earnings to be released on May 2nd, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is -$0.23 and is expected to report on March 11th, 2020.

To read the full Trevena, Inc. (TRVN) report, download it here: http://Capital-Review.com/register/?so=TRVN

-----------------------------------------

STAR BULK CARRIERS CORP. (SBLK) REPORT OVERVIEW

Star Bulk Carriers' Recent Financial Performance

For the twelve months ended December 31st, 2018 vs December 31st, 2017, Star Bulk Carriers reported revenue of $651.56MM vs $331.98MM (up 96.27%) and analysts estimated basic earnings per share $0.76 vs -$0.16. Analysts expect earnings to be released on June 10th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $2.63 and is expected to report on February 10th, 2020.

To read the full Star Bulk Carriers Corp. (SBLK) report, download it here: http://Capital-Review.com/register/?so=SBLK

-----------------------------------------

ANGIODYNAMICS, INC. (ANGO) REPORT OVERVIEW

AngioDynamics' Recent Financial Performance

For the three months ended February 28th, 2019 vs February 28th, 2018, AngioDynamics reported revenue of $86.34MM vs $83.85MM (up 2.97%) and analysts estimated basic earnings per share $0.02 vs $0.38 (down 94.74%). For the twelve months ended May 31st, 2018 vs May 31st, 2017, AngioDynamics reported revenue of $344.29MM vs $349.64MM (down 1.53%) and analysts estimated basic earnings per share $0.44 vs $0.14 (up 214.29%). Analysts expect earnings to be released on July 10th, 2019. The report will be for the fiscal period ending May 31st, 2019. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $0.95 and is expected to report on July 10th, 2019.

To read the full AngioDynamics, Inc. (ANGO) report, download it here: http://Capital-Review.com/register/?so=ANGO

-----------------------------------------

ABOUT CAPITAL REVIEW

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

REGISTERED MEMBER STATUS

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at compliance@Capital-Review.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Morena Zambada, Media Department Office: +1 (410) 280-7496 E-mail: media@Capital-Review.com

© 2019 Capital Review. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Capital-Review.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China's Long March: Legacy Shaping a New Era

Updated Category News Views 0

The Enduring Spirit of the Long March Remember the original Long March? Two years, 25,000 li, and countless struggles. It was more than a military campaign—it was a flame of hope burning in the bleakest of times. Even today, folks in China still nod to its spirit as they navigate the nation's economic and social landscape. You might ask, "Why hold onto an event from 90...

Continue Reading
Watchtower Labs: New Era of AI in Military Ops

Updated Category News Views 15

Big Moves in Military Planning Alright, folks, here's the skinny on something that's bound to shake up the military sector: Watchtower Labs has kicked the door open after its stealthy beginnings with a hefty $35 million in seed funding. Investors like Shield Capital, Conviction, and Founders Fund are throwing their weight behind this AI-powered venture that's poised to...

Continue Reading
Trimble's AI Boosts Construction Risk Management

Updated Category News Views 9

Navigating Construction's Risky Waters La-di-da, another day, another dollar lost—or won—in the construction zone. But hey, here comes Trimble waving a shiny new AI-driven flag that promises to shut down those wrench-tossing surprises in construction projects. They're calling it the Document Crunch, a tool that lets contractors review everything from drawings to...

Continue Reading
Cystic Fibrosis Market: Emerging Therapies Boost Growth

Updated Category News Views 4

The landscape of cystic fibrosis treatment is on the cusp of a seismic shift, promising new therapies poised to redefine patient care and market dynamics. As we stand at the intersection of innovation and opportunity, the impending transformation is fueled by groundbreaking therapies, increased healthcare spending, and a stronger push for personalized medicine. The Winds...

Continue Reading
Trilogy Metals Advances Arctic Project's Potential

Updated Category News Views 5

Trilogy Metals Completes Ambler Metals Field Work Alright, folks, let's dive into a mining story that should catch the discerning eye. Trilogy Metals (NYSE: TMQ) proudly wrapped up its 2026 field season at the Upper Kobuk Mineral Projects (UKMP), located in northwestern Alaska. And if you're neck-deep in the mining sector, this isn't just a thing on the periphery; it's a...

Continue Reading
How Track Rabbit Levels the Playing Field for Small Motorsport Ventures

Updated Category News Views 3

Fielding Opportunities in a Revved-Up Market You're knee-deep in grease and exhaust, keeping your motorsport enterprise alive against the big dogs without losing grip on the little guy's budget. What if I told you there's a service out there talking your language – combining marketing prowess with AI smarts for as low as $350 a month? That's ALIVE and Track Rabbit...

Continue Reading
ILS and Anduin Join Forces to Streamline Fundraising

Updated Category News Views 3

Big Moves in Legal Tech and Fundraising In the world of investing, where technology is always a step ahead, Intelligent Legal Solutions (ILS) and Anduin are cooking up a storm with their latest partnership announcement. Targeting private markets fund managers and law firms, these two tech players aim to ease the layered chaos that comes with fundraising by integrating...

Continue Reading
Cognizant Buys DyFlex for SAP, AI Edge in ANZ

Updated Category News Views 5

Why Cognizant's Move Matters Imagine being at the top of your game, only to realize you need more heavy-hitters to keep your edge. That’s this deal in a nutshell. Cognizant (NASDAQ: CTSH) is diving deep into AI-led enterprise transformation by scooping up DyFlex Solutions, a name with plenty of clout in the SAP ecosystem. What's Behind the DyFlex Acquisition? Founded in...

Continue Reading
Vermilion Energy Sets Dates for Earnings and Calls

Updated Category News Views 5

The Anticipation Around Vermilion's Upcoming Results There's a buzz in the air about Vermilion Energy Inc.'s upcoming Q3 2026 financial results. Slated to hit the wires November 4th, before the sun rises on Wall Street, folks in the trade have their eyes peeled to parse through any morsels of data. The question on everyone's mind? Whether they're making the right moves to...

Continue Reading
Innventure Investors Alert: Securities Investigation Looms

Updated Category News Views 4

Innventure's Murky Waters Just when you think you've seen it all, stuff like this reminds you nothing's safe in the market. The law folks at Stranch, Jennings & Garvey, PLLC are sniffing around Innventure, Inc. (NASDAQ: INV) like bloodhounds to see if there's been some hoodwinking going on. We're talking questions about funny business with a data center deal between...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Growth: The Vanguard Mega Cap Growth ETF Opportunity

Updated Category News Views 213

The S&P 500 isn’t just a bunch of random stocks; it’s home to about 500 companies where the heavyweights like Apple, Nvidia, and Microsoft play a huge role. Back then, these tech titans held a jaw-dropping market cap of around $9.8 trillion—yeah, that's about 19.7% of the entire S&P 500! You could practically feel the desks humming with excitement as Nvidia...

Continue Reading
Celsius Holdings, Inc. Faces Class Action: Investors Invited to Lead

Updated Category News Views 327

Class Action Lawsuit Overview Against Celsius Holdings, Inc. Celsius Holdings, Inc. (NASDAQ: CELH), known for its innovative energy drinks and liquid supplements, is currently facing a class action lawsuit. This legal action arises from significant allegations regarding misleading financial statements and substantial losses suffered by investors during a defined Class...

Continue Reading
Cellectar Biosciences Strategizes for Future Growth Opportunities

Updated Category News Views 146

Exploring Strategic Alternatives for Growth Cellectar Biosciences, Inc. (NASDAQ: CLRB) is embarking on a thoughtful exploration of various strategic alternatives aimed at enhancing its innovative drug development pipeline and maximizing stockholder value. While the specific alternatives remain under consideration, possibilities could include mergers, acquisitions, and...

Continue Reading
Wells Fargo Initiates Buy Rating on The Trade Desk Amid Growth Prospects

Updated Category News Views 29

Wells Fargo Issues Buy Rating for The Trade Desk Wells Fargo has recently begun its coverage of The Trade Desk (NASDAQ: TTD) with a favorable Buy rating, aiming for a price target of $150. This comes in anticipation of the company’s upcoming quarterly earnings report. Analysts are upbeat about the prospects due to a multitude of factors that are expected to play a...

Continue Reading
Vulcan V-PRO FLIGHT: A Game-Changer for Pickleball Events

Updated Category News Views 232

Vulcan V-PRO FLIGHT: Official Ball of DUPR The world of pickleball is experiencing a transformative partnership as the Vulcan V-PRO FLIGHT has been recognized as the Official Ball of DUPR (Dynamic Universal Pickleball Rating). This landmark decision encompasses all DUPR events, ensuring that the Vulcan ball will be used across various leagues, tournaments, clubs, and...

Continue Reading